Coronary disease & ACSGuideline or statement

Mitochondrial Targets in Ischaemic Heart Disease and Heart Failure, and their Potential for a More Efficient Clinical Translation. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

Eur J Heart FailPublished

  • Scientific statement

Scope

As issued by the authors

Mitochondrial targets in ischaemic heart disease and HF: recent research advances on mitochondrial alterations in myocardial infarction (MI), reasons for failed clinical translation of mitoprotective strategies and remaining obstacles (timing of drug administration, tissue bioavailability, efficient mitochondrial targeting, impact of risk factors, comorbidities and comedications)

Original publication

Mitochondrial Targets in Ischaemic Heart Disease and Heart Failure, and their Potential for a More Efficient Clinical Translation. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function. Eur J Heart Fail. Published 4 May 2025. doi:10.1002/ejhf.3674

Summarised from the published abstract; every number is checked against it